Agenus (AGEN) EBT Margin Growth (1y) (2011 - 2026)

Agenus (AGEN) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,526.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -683.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 452.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Agenus 184.05 Mn 177.29 Mn 33.74 Mn 11,034.00

Historic Data

Download Data
DateValue
Mar 31, 2026 11,034.00
Dec 31, 2025 17,035.00
Sep 30, 2025 24,873.00
Jun 30, 2025 14,878.00
Mar 31, 2025 11,626.00
Dec 31, 2024 -16,940.00
Sep 30, 2024 -7,955.00
Jun 30, 2024 -4,807.00
Mar 31, 2024 1,538.00
Dec 31, 2023 -13,670.00
Sep 30, 2023 -673.00
Jun 30, 2023 -185.00
Mar 31, 2023 -9,958.00
Dec 31, 2022 40,370.00
Sep 30, 2022 -23,818.00
Jun 30, 2022 99,642.00
Mar 31, 2022 23,810.00
Dec 31, 2021 -20,107.00
Sep 30, 2021 39,634.00
Jun 30, 2021 -102,933.00